Novo Nordisk ( NYSE:NVO ) made waves in the pharmaceutical industry as its stock skyrocketed to unprecedented heights following the announcement of groundbreaking results from its experimental oral weight-loss drug, amycretin. The drugmaker's innovative approach, which combines GLP-1 and amylin hormones, surpassed expectations by demonstrating remarkable efficacy...
It seems NOVO is ending x in a corrective xyz of (4) Target 600 during april 2022 before further upside during the rest of the year
Is seems NOVO is about to finish a minor wave 2 now to continue higher with an impulse to 5 There should be a long way to go still and targets between 1000 and 1400 are in reach
NOVO_B Jeg tror på å falle i disse dager volume +vwap
After having consolidated from its most recent rise, Novo Resources seems to have enter its wave iii of 3, the usually the most bullish phase.
My analysis of Novo Nordisk as of 6.12.2020 With the current recommendation for "buy" with my eyes (short term)
The last anaylsis of Novo Nordisk was successful at its prediction. Heres an updated one of where i see it in the short term future
Novo Resources ( TSXV:NVO ) is about to end a massive triangle, completion to be expected before the end of August 2019. My bet, with gold back in bullmarket, is that Novo will move strongly upward. Background: this junior is active in the Western Australian Pilbara region and has found massive gold resources, being researched now for inclusion in the M&I...
TSX:NVO seems to have completed it's wave (2) of 3 correction, has started its wave (3) of 3, the most impulsive and powerful wave. The break above the $6.4o area would invalidate the most basic bearish count and a break above $6.80 would give credit to the bullish scenario. This idea is valid as long as the key support of $3.80/$4.00 area holds.
Rounded bottom formed on CAI, with no clear overhead resistance the first target on the break is 7.6c representing a 58% move from current levels. Recent JV with TSXV:NOV and a very nice set of tenements.